Synchronoss Technologies, Inc. (NASDAQ: SNCR), the world’s leading provider of transaction management, cloud enablement and mobility management for co...
ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces the opening of...
Watson Pharmaceuticals, Inc. announced plans to establish a Global R&D Technology Center in North Brunswick, New Jersey. The Company has signed a leas...